AU3473193A - Treatment for atherosclerosis - Google Patents

Treatment for atherosclerosis

Info

Publication number
AU3473193A
AU3473193A AU34731/93A AU3473193A AU3473193A AU 3473193 A AU3473193 A AU 3473193A AU 34731/93 A AU34731/93 A AU 34731/93A AU 3473193 A AU3473193 A AU 3473193A AU 3473193 A AU3473193 A AU 3473193A
Authority
AU
Australia
Prior art keywords
atherosclerosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34731/93A
Inventor
Charles David Broaddus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU3473193A publication Critical patent/AU3473193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
AU34731/93A 1992-01-17 1993-01-14 Treatment for atherosclerosis Abandoned AU3473193A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82310192A 1992-01-17 1992-01-17
US823101 1992-01-17
US88240192A 1992-05-13 1992-05-13
US882401 1992-05-13

Publications (1)

Publication Number Publication Date
AU3473193A true AU3473193A (en) 1993-08-03

Family

ID=27124708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34731/93A Abandoned AU3473193A (en) 1992-01-17 1993-01-14 Treatment for atherosclerosis

Country Status (3)

Country Link
AU (1) AU3473193A (en)
MX (1) MX9300240A (en)
WO (1) WO1993013801A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU689775B2 (en) * 1993-05-14 1998-04-09 Procter & Gamble Company, The Cholesterol lowering drink mix compositions
WO1999001149A1 (en) * 1997-06-30 1999-01-14 Sigma Pharmaceuticals Pty. Ltd. Health supplement

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL343851A1 (en) * 1997-12-12 2001-09-10 Warner Lambert Co Antihyperlipidemic statin-lp(a) inhibitor combinations
US6235311B1 (en) 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
JP2001253827A (en) * 2000-02-15 2001-09-18 Pfizer Prod Inc Composition and method for treating osteoporosis
US20050250734A1 (en) * 2003-11-07 2005-11-10 The Procter & Gamble Company Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels
MY151322A (en) 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083972A (en) * 1973-06-19 1978-04-11 The Procter & Gamble Company Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4849222A (en) * 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
CA2007641A1 (en) * 1989-02-01 1990-08-01 Donald S. Karanewsky Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CA2016467A1 (en) * 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU689775B2 (en) * 1993-05-14 1998-04-09 Procter & Gamble Company, The Cholesterol lowering drink mix compositions
WO1999001149A1 (en) * 1997-06-30 1999-01-14 Sigma Pharmaceuticals Pty. Ltd. Health supplement

Also Published As

Publication number Publication date
WO1993013801A1 (en) 1993-07-22
MX9300240A (en) 1994-07-29

Similar Documents

Publication Publication Date Title
AU4166393A (en) Auto-reclosers
AU3377093A (en) Sulphonylbenzyl-substituted pyridones
AU4247593A (en) Imidazoles for the treatment of atherosclerosis
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3803593A (en) Compounds
AU4177593A (en) Benzophenonehydrazones
AU4987893A (en) Waste processing
AU3042892A (en) Rockbolt
AU3710993A (en) Biphenylmethyl-substituted pyridones
AU4272193A (en) Sludge scraping-up apparatus
AU4156393A (en) Heterocyclyltriazolinones
AU664253B2 (en) Photo-deviometer
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3473193A (en) Treatment for atherosclerosis
AU656651B2 (en) Corpuscle-detecting apparatus
AU4164793A (en) Heterocyclyltriazolinones
AU4632493A (en) Weathershed
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU4316993A (en) Polyaniles
AU5564794A (en) Play-mark
AU3759793A (en) Compounds
AU4261793A (en) Wedge-welding method